Drug Shortage Report for MYLAN-ATORVASTATIN
Report ID | 57023 |
Drug Identification Number | 02392933 |
Brand name | MYLAN-ATORVASTATIN |
Common or Proper name | ATORVASTATIN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ATORVASTATIN |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 90 BT, 500 BT |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-10-11 |
Actual start date | |
Estimated end date | 2018-10-19 |
Actual end date | 2018-10-09 |
Shortage status | Avoided shortage |
Updated date | 2018-10-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v19 | 2018-10-09 | French | Compare |
v18 | 2018-10-09 | English | Compare |
v17 | 2018-10-03 | French | Compare |
v16 | 2018-10-03 | English | Compare |
v15 | 2018-10-03 | English | Compare |
v14 | 2018-10-01 | French | Compare |
v13 | 2018-10-01 | English | Compare |
v12 | 2018-09-24 | French | Compare |
v11 | 2018-09-24 | English | Compare |
v10 | 2018-09-20 | French | Compare |
v9 | 2018-09-20 | English | Compare |
v8 | 2018-09-13 | French | Compare |
v7 | 2018-09-13 | English | Compare |
v6 | 2018-09-13 | French | Compare |
v5 | 2018-09-13 | English | Compare |
v4 | 2018-08-30 | French | Compare |
v3 | 2018-08-30 | English | Compare |
v2 | 2018-07-31 | French | Compare |
v1 | 2018-07-31 | English | Compare |
Showing 1 to 19 of 19